<DOC>
	<DOCNO>NCT01520467</DOCNO>
	<brief_summary>There currently drug pediatric marketing authorization capable limit advance bone maturation child aggressive adrenarche . Estrogens principal actor involve bone maturation premature epiphyseal fusion . Aromatase inhibitor , use treatment hormone-dependent cancer , block transformation androgens estrogen . Third generation inhibitor , Anastrozole one , appear well tolerated child sometimes use within framework clinical trial limit bone maturation improve prognosis respect final size , notably child treat growth hormone ( GH ) due GH deficit . Nevertheless , data report base small sample size include child pathological adrenarche .</brief_summary>
	<brief_title>Aromatase Inhibitor Bone Maturation , Children With Silver Russell Prader-Willi Syndrome</brief_title>
	<detailed_description>Silver-Russell syndrome ( SRS ) , occur secondary imprint disorder due anomalous methylation chromosome 11 due uniparental disomy chromosome 7 , rare syndrome ( ORPHA813 , OMIM 180860 ) characterize growth retardation intrauterine onset , normal head circumference , small postnatal size major feed difficulty . Starting young age , rapid age bone occur even absence central puberty , association production androgens adrenal gland ( adrenarche ) . This advance bone maturation compromise final size , even child receives growth hormone ( GH ) treatment several year . Prader-Willi syndrome ( PWS ) also rare disease ( ORPHA739 , OMIM 176270 ) , occur secondary imprinting disorder due anomaly chromosome 15 ( paternal deletion maternal disomy ) . These child also present feed difficulty first year life , well small size . They frequently treat GH , bone age increase course adrenarche , certain patient SRS .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Prader-Willi Syndrome</mesh_term>
	<mesh_term>Silver-Russell Syndrome</mesh_term>
	<mesh_term>Aromatase Inhibitors</mesh_term>
	<mesh_term>Anastrozole</mesh_term>
	<criteria>Patients genetically proven SRS PWS , treatment GH usual context disease , present adrenarche ( define either DHEAS level function age appearance pubic hair ) associate bone age least 6 month great chronological age absence onset central puberty ( LH peak ≤ LH peak prepubertal patient , accord standard laboratory perform GnRH stimulation test LH FSH , date back less 3 month ) . Patients medical coverage . The low age limit inclusion 5 year upper age limit 10 complete year girls 12 complete year boys . The maximum bodymass index ( BMI ) Zscore inclusion +4 Patients capable swallow pill size experimental drug . Renal insufficiency ( creatinine clearance , calculate accord Schwartz formula , low 70ml/min/l , 73 m² ) , Hepatic insufficiency ( prothrombin ratio &lt; 50 % factor V &lt; 50 % ) , Hepatic cytolysis ( liver transaminase level great twice normal level age ) , cholestasis ( gammaglutamyl transferase ( GGT ) level great twice normal level age ) , Contraindication one component Anastrozole placebo . Patients scoliosis require surgery .</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>SRS</keyword>
	<keyword>PWS</keyword>
	<keyword>pathological adrenarche</keyword>
	<keyword>aromatase inhibitor</keyword>
	<keyword>Children</keyword>
</DOC>